AAPGV Tambahing bathi saben saham ing taun lumaku Ascentage
Premium pricing for innovative leukemia drugs strengthens the market position of Ascentage Pharma Group (AAPGV). This chart on GURU.Markets provides a year-over-year EPS comparison, with the indicator currently standing at 75.70. The development of senolytic agents through partnerships with biopharma companies and its status as a global leader in targeted oncology ensure the brand's resilience.
Rincian metrik keuangan lan pasar Ascentage Pharma Group International (AAPGV)
- nilai pasar lan prakiraan target analis:
- data kapitalisasi pasar:
- rincian valuasi buku bisnis:
- indikator beban utang lan likuiditas:
Koefisien Total Utang marang Modal Ascentage Pharma Group|AAPGV - Utang jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas Ascentage Pharma|AAPGV - Gunggung utang perusahaan|Utang-utang marang nilai buku Ascentage Pharma Group|AAPGV - Utang jangka dawa perusahaan|Tanggungan utang jangka cendhak perusahaan Ascentage Pharma|Rasio likuiditas perantara ascentage.com
- indikator profitabilitas perusahaan lan kelipatan valuasi:
AAPGV - Bathi resik|Proyeksi bathi mangsa ngarep Ascentage Pharma Group|AAPGV - Pangali P/E|Pangali forward rega marang bathi Ascentage Pharma Group|AAPGV - Pangali PEG|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Ascentage Pharma Group International|AAPGV - Bathi operasional sadurunge ngurangi amortisasi|Bathi saben saham sajroning taun lumaku Ascentage Pharma|AAPGV - Bathi saben saham sajrone rolas wulan pungkasan|Dinamika bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan ascentage.com|AAPGV - Wutah bathi ing taun lumaku|Dinamika bathi saben saham sing diarepake ing taun ngarep Ascentage Pharma Group
- informasi babagan volume dodolan lan pendapatan:
Pambiji fundamental:AAPGV Ascentage
Ascentage Pharma Group operates in the high-risk sector of targeted oncology drug development, characterized by capital-intensive clinical trials. Analyzing current year-over-year EPS dynamics, an investor can observe the percentage deviation of net income per share, which reveals the impact of raw material and logistics costs on the bottom line. The positive trend confirms the effectiveness of the patent strategy and the scalability of a model devoid of manufacturing capital expenditures.
Pesaing utama
Kacepetan wutah bathi saben saham ing taun lumaku BeiGene Corp (ONC)|HALO (Halozyme Therapeutics, Inc.) - Wutah bathi ing taun lumaku|Kacepetan wutah bathi saben saham ing taun lumaku revmed.com RVMD|Wutah bathi ing taun lumaku AAPG|Wutah bathi resik saben saham ing taun iki CG Oncology CGON|Wutah bathi saben saham ing taun lumaku UroGen URGN|Prakiraan wutah bathi resik saben saham ing taun iki Bicara Bio (BCAX)|PSNL - Wutah bathi saben saham ing taun lumaku|ERAS - Wutah bathi ing taun lumaku|DCTH: Wutah bathi ing taun lumaku|Y-mAbs Therapeutics, Inc. (YMAB) - Wutah bathi ing taun lumaku|Wutah bathi resik saben saham ing taun iki AURA|Kacepetan wutah bathi saben saham ing taun lumaku candeltx.com CADL|Wutah bathi ing taun lumaku ARAY|SLS (SELLAS Life Sciences Group, Inc.) - Tambahing bathi saben saham ing taun lumaku|Wutah bathi ing taun lumaku ACTU (Actuate Therapeutics Inc)|Tambahing bathi saben saham ing taun lumaku CTOR|tuhurabio.com - Wutah bathi ing taun lumaku|Tambahing bathi saben saham ing taun lumaku TARA (Protara Therapeutics)|Fate Therapeutics, Inc. (FATE) - Wutah bathi saben saham ing taun lumaku|WHWK - Prakiraan wutah bathi resik saben saham ing taun iki|Wutah bathi saben saham ing taun lumaku tscan.com|CSBR: Tambahing bathi saben saham ing taun lumaku|Wutah bathi saben saham ing taun lumaku XBiotech USA (XBIT)|CVM: Dinamika bathi saben saham ing taun lumaku|Wutah bathi saben saham ing taun lumaku ostherapies.com OSTX|Wutah bathi resik saben siji saham kanggo taun lumaku RADX (Radiopharm Theranostics Limited)|Artiva - Wutah bathi ing taun lumaku|ANL: Wutah bathi saben saham ing taun lumaku|VERU: Wutah bathi ing taun lumaku|Dinamika bathi saben saham ing taun lumaku TPST (Tempest Tx)|XLO (Xilio Therapeutics) - Wutah bathi ing taun lumaku|Kacepetan wutah bathi saben saham ing taun lumaku renovarobio.com RENB|Wutah bathi saben saham ing taun lumaku muraloncology.com (MURA)|Wutah bathi resik saben siji saham kanggo taun lumaku KAPA|Wutah bathi ing taun lumaku OKUR (onkuretherapeutics.com)|Wutah bathi resik saben siji saham kanggo taun lumaku GDTC (CytoMed)|Curis - Wutah bathi ing taun lumaku|APLM: Wutah bathi saben saham ing taun lumaku|Tharimmune (THAR) - Wutah bathi saben saham ing taun lumaku|Wutah bathi resik saben saham ing taun iki Advanced Biomed Inc.|GNPX (Genprex Inc) - Wutah bathi ing taun lumaku|Calidi Biotherapeutics (CLDI) - Prakiraan wutah bathi resik saben saham ing taun iki|Wutah bathi ing taun lumaku SBFM|Wutah bathi saben saham ing taun lumaku XBIO (Xenetic Biosciences, Inc.)|Wutah bathi ing taun lumaku SLRX (salariuspharma.com)|PPBT - Wutah bathi resik saben saham ing taun iki|AONC - Wutah bathi saben saham ing taun lumaku|Tambahing bathi saben saham ing taun lumaku BGNE (BeOne Medicines)|CKPT: Wutah bathi ing taun lumaku|Elevation Oncology Inc. (ELEV) - Wutah bathi ing taun lumaku|ICAD (iCAD) - Wutah bathi ing taun lumaku|Wutah bathi ing taun lumaku ikenaoncology.com|Wutah bathi ing taun lumaku NTBL|Wutah bathi ing taun lumaku Viracta Therapeutics Inc. (VIRX)|Wutah bathi saben saham ing taun lumaku MorphoSys Inc MOR|Tambahing bathi saben saham ing taun lumaku NAYA
